Genomic Locus Targeting for Stable Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The generation of mammalian cell lines with high and stable expression of recombinant proteins is challenging due to variable expression and silencing caused by epigenetic mechanisms related to genomic integration sites, making the selection of suitable stably transfected cell lines an arduous process.
Innovation Solution
Integration of exogenous nucleic acid sequences into mammalian cells at specific loci with extended methylation-free CpG islands, such as the promoter regions of genes like hnRNPA2, TATA binding protein, beta-actin, and PDCD2, to enhance protein expression stability and levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If transgene is integrated into random genomic locations, then integration process is simple, but expression level and stability are highly variable and subject to silencing
Solution Approach 1:
The patent identifies and characterizes specific genomic loci with extended methylation-free CpG islands in advance as optimal integration sites. By pre-selecting these locations based on their epigenetic properties, the invention ensures that transgenes integrated at these sites will maintain stable expression without requiring complex post-integration screening processes.
Solution Approach 2:
The invention applies the principle of local quality by targeting specific genomic regions with unique epigenetic characteristics (extended methylation-free CpG islands) rather than random integration. These localized regions provide a favorable genomic environment that actively promotes stable transgene expression, creating a quality difference between integration sites.
2Reliability
If transgene is integrated at specific loci with extended methylation-free CpG islands, then expression stability and level are enhanced, but integration process becomes more complex
Solution Approach 1:
The invention changes the parameter of integration site selection from random to specific loci defined by epigenetic parameters (extended methylation-free CpG islands). This parameter change in the integration strategy directly improves expression stability while the complexity is managed through the use of established targeted integration methods.
3Productivity
If transgene is integrated at specific loci with extended methylation-free CpG islands, then protein expression level is significantly enhanced, but selection process becomes more demanding
Solution Approach 1:
By pre-identifying loci with extended methylation-free CpG islands as optimal integration sites, the invention performs the selection criterion establishment in advance. This preliminary action ensures high expression levels without requiring demanding post-integration screening, as the selected loci inherently provide the necessary expression characteristics.
Data Source
AI summary
The present disclosure provides compositions and methods for enhanced expression of exogenous genes in eukaryotic cells. The method involves introducing into a mammalian cell an exogenous nucleic acid. wherein the exogenous nucleic acid intearates into a locus of the genome that comprises an extended methylation-free CpG island. Also provided are chromosomal loci, sequences for enhanced and stable expression of exogenous genes.